Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-016717
Filing Date
2015-03-17
Accepted
2015-03-17 16:02:11
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v403198_10k.htm 10-K 1316325
2 EXHIBIT 23.1 v403198_exh23x1.htm EX-23.1 4236
3 EXHIBIT 31.1 v403198_exh31x1.htm EX-31.1 15037
4 EXHIBIT 31.2 v403198_exh31x2.htm EX-31.2 15050
5 EXHIBIT 32.1 v403198_exh32x1.htm EX-32.1 6748
12 GRAPHIC line.gif GRAPHIC 43
13 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-15-016717.txt   7212493

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cpxx-20141231.xml EX-101.INS 974512
7 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20141231.xsd EX-101.SCH 50514
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20141231_cal.xml EX-101.CAL 57133
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20141231_def.xml EX-101.DEF 274322
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20141231_lab.xml EX-101.LAB 379530
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20141231_pre.xml EX-101.PRE 337762
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36179 | Film No.: 15706341
SIC: 2834 Pharmaceutical Preparations